Article Data

  • Views 343
  • Dowloads 142

Case Reports

Open Access

Symptom management in a patient with end-stage ovarian cancer: case report

  • R. Moretti1,*,
  • B. Pizzi2
  • M.T. Colizza3
  • G. Carta4

1Intensive Care Unit, Italy

2Department of Anesthesiology, Italy

3Hospital of Avezzano, Italy

4Department of Obstetrics and Gynaecology, University of L'Aquila, Italy

DOI: 10.12892/ejgo200704325 Vol.28,Issue 4,July 2007 pp.325-327

Published: 10 July 2007

*Corresponding Author(s): R. Moretti E-mail:

Abstract

Bowel obstruction is a common complication in patients with far advanced abdominal or pelvic cancer. In patients with recurrent or advanced disease, where options for curative treatment have been exhausted, palliation of symptoms with minimal additional morbidity is the aim of therapy. Owing to the difficulties inherent in conducting perspective randomized trials, clinicians face a significant challenge in managing terminally ill obstructed patients. We evaluated the case of a woman with ovarian cancer. Clinically, the objective of the study was to focus attention on the most up-to-date evidence concerning the treatment of malignant bowel obstruction.

Keywords

Bowel obstruction; Ovarian cancer; Palliation; Octreotide

Cite and Share

R. Moretti,B. Pizzi,M.T. Colizza,G. Carta. Symptom management in a patient with end-stage ovarian cancer: case report. European Journal of Gynaecological Oncology. 2007. 28(4);325-327.

References

[1] Beattie G.J., Leonard R., Smyth J.F.: "Bowel obstruction in ovarian carcinoma: a retrospective study and rewiew of the literature". Pall. Med., 1989, 3, 275.

[2] Gallick H.L., Weaver D.W., Sachs R.J., Bouwman D.L.: "Intesti nal obstruction in cancer patients. An assessment of risk factors and outcome". Am. Sur., 1986, 52, 434.

[3] Van Oojen B., Van Der Burg MEL, Planting ASTh, Siersema P.O., Wiggers T.: "Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin". Surg. Gynecol. Obstet., 1993, 176, 469.

[4] Lau P.W., Lorentz T.G.: "Results of Surgery for malignant bowel obstruction in advanced, unresectable, recurrent colorectal cancer". Dis. Col. Rect., 1993, 36, 61.

[5] Baines M., Oliver DJ., Carter R.L.: "Mechanical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study". Lancet, 1985, 11, 990.

[6] Fainsinger R.L., Spachynsky K., Hanson J., Bruera E.: "Symptom control in terminally ill patients with malignant bowel obstruction". J. Pain Symp. Manage., 1994, 9, 12.

[7] Jong P., Sturgeon J., Jameison J.C.: "Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer". Can. J. Surg., 1995, 38, 454.

[8] Freuer D.J., Broadley K.E., Shepherd J.H., Barton D.P.J.: "Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer". Gynecol Oneal., 1999, 75, 313.

[9] Mercadante S.: "A ssessment and management of mechanical bowel obstruction". In: Portenoy R.K., Bruera E., (eds.): "Topics in Palliative Care". New York, Oxford University Press, 1997, 113.

[10] Ripamonti C., Twycross R., Baines M., Bozzetti F.. Capri S., De Conno F. et al.: "Clinical-practice recommendations for the management of bowel obstruction in patients with end stage cancer" Support Care Cancer , 2001, 19, 23.

[11] Pictus D., Marx M.V., Weyman P.J.: "Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement". Am. J Radiol., 1988, 150, 295.

[12] Mercadante S., Ferrera P., Villari P., Marrazzo A.: "Aggressive pharmacological treatment for reversing malignant bowel obstruction". J. Pain Symp. Manage., 2004, 28.

[13] Ripamonti C., Mercadante S.: "Pathophysiology and management of malignant bowel obstruction". In: Doyle D., Hanks G.W.C., MacDonald N., (eds.): "Oxford Textbook of Palliative Medicine", New York, Oxford University press, 2002, 196.

[14] Nellgard P., Bojo L., Cassuto J.: "Importance of vasoactive intestinal peptide and somatostatin for fluid losses in small bowel obstruction". Scand. J. Gastroenterol., 1995, 30, 464.

[15] Jafri S., Posricha P.J.: "Octreotide". In Goodman G.A. (ed.): "Basi Fannacologiche Della Terapia". New York, McGraw Hill, 2003, 988.

[16] Ripamonti C., Mercadante S., Groff L., Zecca E., De Conno F., Casuccio A.: "Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: A prospective randomizedtrial". J. Pain Symp. Manage., 2000, 19.

[17] Matulonis U., Seiden M.V., Roche M., Kranser C., F uller A., Atkinsons T. et al.: "Long acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer". J. Pain Symp. Manage., 2005, 30, 563.

[18] Ripamonti C., Panzeri C., Groff L., Galeazzi G., Boffi R.:'The role of somatostatin and octreotide in bowel obstruction: Pre-clinical and clinical results". Tumori, 2001, 87, 1.

[19] Ventafridda V., Ripamonti C., Caraceni A., Spoldi E., Messina L., De Conno F.: "The management of inoperable gastrointestinal obstruction in terminal cancer patients". Tumori, 1990, 76, 389.

[20] De Conno F., Caraceni A., Zecca E., Spoldi E., Ventafridda V "Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction". J. Pain Symp. Manage., 1991, 6, 484.

[21] Ripamonti C., Fagnoni E., Magni A.: "Management of symptoms due to inoperable bowel obstruction". Tumori, 2005, 91, 233.

[22] Ripamonti C., Gemlo B.T., Bozzetti F., De Conno F.: "Role of enteral nutrition in advanced cancer patients: indications and contraindications of the different techniques employed". Tumori , 1996, 82, 302.

[23] Htinerbein M., Krause M., Moesta K.T., Rau B., Schlag P.M.: "Palliation of malignant rectal obstruction with self-expanding metal stents". Surgery, 2005, 137, 42.

[24] Rao A., Land R, Carter J.: "Management of upper gastrointestinal obstruction in advanced ovarian cancer with intraluminal stents". Gynecol. Oneal., 2004, 95, 739.

[25] Hardy J., Ling J., Mansi J., Isaacs R., Bliss J., A'Hem R et al. "Pitfalls in placebo controlled trials in palliative care: dexametasone for the palliation of malignant bowel obstruction". J. Palliat. Med., 2000, 14, 437.

[26] Chung C.C., Meng WC., Yu S.C., Ceung K.L., Lau WY., Li A.K. "A prospective study on the use of water-soluble contrast follow through radiology in the management of small bowel obstruction". Aust. N. Z. J. Surg., 1996, 66, 598.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top